Related Experiment Video
Updated: Mar 8, 2026

07:06
Particle Agglutination Method for Poliovirus Identification
Published on: April 20, 2011
16.0K
PVA modification mitigates PVDF hydrophobicity for concurrent protein and glycan analysis
Gang Liu1, Yuqing Li1, Yating Wang1
1College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, Liaoning, China.
Analytica Chimica Acta
|March 6, 2026
Summary
We developed a new method to analyze protein glycosylation on PVDF membranes, improving efficiency and enabling simultaneous protein and glycan analysis for biomarker discovery.
Area of Science:
- Glycoproteomics
- Biomarker Discovery
- Post-Translational Modifications
Background:
- Glycosylation is a crucial protein modification impacting biological and pathological processes.
- Existing glycan analysis methods have limitations, including material loss and inability to reflect native glycosylation.
- Analyzing glycoproteins on PVDF membranes is challenging due to enzyme adsorption and impurities.
Purpose of the Study:
- To develop an improved glycoproteomic strategy for efficient glycan analysis from PVDF membranes.
- To enable simultaneous protein identification and glycan profiling from the same sample.
- To characterize glycosylation differences in apolipoprotein A1 (ApoA1) between pancreatic cancer patients and healthy individuals.
Main Methods:
- Developed a novel strategy involving immersing PVDF membranes in polyvinyl alcohol (PVA) to enhance hydrophilicity.
- This PVA treatment facilitates efficient enzyme-glycoprotein interaction for peptide and glycan release.
- Applied the method to analyze serum apolipoprotein A1 (ApoA1) glycosylation.
Main Results:
- The PVA-treated PVDF membrane strategy enabled efficient and simultaneous release of peptides and glycans.
- Successfully identified and characterized glycosylation features of ApoA1 from patient and healthy samples.
- Demonstrated the method's utility for comparative glycan analysis.
Conclusions:
- The novel PVA-based PVDF membrane treatment overcomes limitations of conventional glycoproteomic methods.
- This approach facilitates simultaneous protein and glycan analysis, crucial for biomarker discovery.
- Provides a foundation for identifying novel glycan-based biomarkers, particularly for diseases like pancreatic cancer.

